E.E.S. 400 Drug Patent Profile
✉ Email this page to a colleague
When do E.e.s. 400 patents expire, and when can generic versions of E.e.s. 400 launch?
E.e.s. 400 is a drug marketed by Arbor Pharms Llc and Azurity and is included in two NDAs.
The generic ingredient in E.E.S. 400 is erythromycin ethylsuccinate. There are one hundred and three drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the erythromycin ethylsuccinate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for E.e.s. 400
A generic version of E.E.S. 400 was approved as erythromycin ethylsuccinate by AZURITY on December 31st, 1969.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for E.E.S. 400?
- What are the global sales for E.E.S. 400?
- What is Average Wholesale Price for E.E.S. 400?
Summary for E.E.S. 400
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 40 |
| DailyMed Link: | E.E.S. 400 at DailyMed |
Pharmacology for E.E.S. 400
| Drug Class | Macrolide Antimicrobial Macrolide |
| Physiological Effect | Decreased Sebaceous Gland Activity |
US Patents and Regulatory Information for E.E.S. 400
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Arbor Pharms Llc | E.E.S. 400 | erythromycin ethylsuccinate | SUSPENSION;ORAL | 061639-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Azurity | E.E.S. 400 | erythromycin ethylsuccinate | TABLET;ORAL | 061905-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Azurity | E.E.S. 400 | erythromycin ethylsuccinate | TABLET;ORAL | 061905-002 | Aug 12, 1982 | BX | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
